Identification of Novel RORγt Inverse Agonist YW-089 as a Preclinical Candidate for the Treatment of Autoimmune Diseases

Abstract Retinoic acid receptor-related orphan receptor γt (RORγt) is a key regulator of IL-17-producing T helper 17 (Th17) cell differentiation and an attractive target for autoimmune diseases. Although RORγt inverse agonists have shown clinical promise, identifying candidates with both high potency and favorable drug-like properties remain challenging. We previously reported the carboxyl-containing biaryl urea compound 3i, which reduced psoriasis severity in mice but exhibited poor microsomal stability and suboptimal pharmacokinetics (38% oral bioavailability in mice). Herein, optimization of sulfone-containing biaryl ureas led to the discovery of compound 4 (YW-089), a potent and selective RORγt inverse agonist (RORγ FRET IC50 = 27 nM; mTh17 IC50 = 140 nM). YW-089 demonstrated markedly improved metabolic stability across species (t1/2 > 145 min), favorable pharmacokinetics in mice, rats, and dogs (oral bioavailability 66%, 65%, and 73%, respectively), and robust efficacy in imiquimod- and IL-23-induced psoriasis mouse models, supporting its further preclinical development for autoimmune diseases.

Authors

Institutions

Publication Details

Journal
Journal of Medicinal Chemistry
Published
2026-11-12
DOI
https://doi.org/10.1021/acs.jmedchem.6c01447
Primary Topic
Psoriasis: Treatment and Pathogenesis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Identification of Novel RORγt Inverse Agonist YW-089 as a Preclinical Candidate for the Treatment of Autoimmune Diseases

Meiqi Song, 张卓君, Qiong Xie, Nannan Sun et al.
Journal of Medicinal Chemistry
Psoriasis: Treatment and Pathogenesis
article

Identification of Novel RORγt Inverse Agonist YW-089 as a Preclinical Candidate for the Treatment of Autoimmune Diseases

Meiqi Song, 张卓君, Qiong Xie, Nannan Sun, Yunpeng Zhao, Yafei Huang, Chenyu Zhu, Yonghui Wang, Huimin Guo, Ting Tang, Mingcheng Yu, Fazhi Yu, Ji’an Chen
article en

Abstract

Abstract Retinoic acid receptor-related orphan receptor γt (RORγt) is a key regulator of IL-17-producing T helper 17 (Th17) cell differentiation and an attractive target for autoimmune diseases. Although RORγt inverse agonists have shown clinical promise, identifying candidates with both high potency and favorable drug-like properties remain challenging. We previously reported the carboxyl-containing biaryl urea compound 3i, which reduced psoriasis severity in mice but exhibited poor microsomal stability and suboptimal pharmacokinetics (38% oral bioavailability in mice). Herein, optimization of sulfone-containing biaryl ureas led to the discovery of compound 4 (YW-089), a potent and selective RORγt inverse agonist (RORγ FRET IC50 = 27 nM; mTh17 IC50 = 140 nM). YW-089 demonstrated markedly improved metabolic stability across species (t1/2 > 145 min), favorable pharmacokinetics in mice, rats, and dogs (oral bioavailability 66%, 65%, and 73%, respectively), and robust efficacy in imiquimod- and IL-23-induced psoriasis mouse models, supporting its further preclinical development for autoimmune diseases.

Journal of Medicinal Chemistry
Fudan University (CN), Zhengzhou University (CN)
Natural Science Foundation of Shanghai, National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality, National Science and Technology Major Project
Good health and well-being
Psoriasis: Treatment and Pathogenesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon